Drs. Justin Abbatemarco, Marius Ringelstein, and Ilya Ayzenberg discuss a new class of complement inhibitors that we're using in NMOSD.
Show reference:
https://www.neurology.org/doi/full/10.1212/WNL.0000000000209888
